scholarly journals Severe Asthma Associated with Myasthenia Gravis

2014 ◽  
Vol 21 (1) ◽  
pp. e1-e3 ◽  
Author(s):  
Natasha Satkunam ◽  
Zaeem A Siddiqi ◽  
Dilini Vethanayagam

Severe asthma constitutes a subgroup of approximately 10% of all asthma cases. Approximately one-half of these individuals have a refractory form of the disease in which atopy and T-helper cell 2-skewed immunological response may not be as closely linked to the disease as in other phenotypes of asthma. This suggests that not all asthma is explained by a T-helper cell 2-skewed immunological response, and that other immunological mechanisms may be important in this category of nonatopic asthma. The authors present a case involving a 55-year-old Caucasian man with nonatopic, adult-onset asthma, nonsteroidal anti-inflammatory drug sensitivity and idiopathic urticaria. This individual presented two years following his initial asthma diagnosis with diplopia and mild ptosis, and was subsequently diagnosed with seropositive myasthenia gravis.

Neurology ◽  
1987 ◽  
Vol 37 (8) ◽  
pp. 1405-1405 ◽  
Author(s):  
J. D. Bowen ◽  
P. Kidd

2010 ◽  
Vol 112 (2) ◽  
pp. 386-393 ◽  
Author(s):  
Wilson Z. Ray ◽  
Rahul Kasukurthi ◽  
Esther M. Papp ◽  
Amy M. Moore ◽  
Andrew Yee ◽  
...  

Object Peripheral nerve allografts provide a temporary scaffold for host nerve regeneration and allow for the repair of significant segmental nerve injuries. Despite this potential, nerve allograft transplantation requires temporary systemic immunosuppression. Characterization of the immunological mechanisms involved in the induction of immune hyporesponsiveness to prevent nerve allograft rejection will help provide a basis for optimizing immunomodulation regimens or manipulating donor nerve allografts to minimize or eliminate the need for global immunosuppression. Methods The authors used C57Bl/6 mice and STAT4 and STAT6 gene BALB/c knockout mice. A nonvascularized nerve allograft was used to reconstruct a 1-cm sciatic nerve gap in the murine model. A triple costimulatory blockade of the CD40, CD28/B7, and inducible costimulatory (ICOS) pathways was used. Quantitative assessment was performed at 3 weeks with nerve histomorphometry, walking track analysis, and the enzyme-linked immunospot assay. Results The STAT6 −/− mice received 3 doses of costimulation-blocking antibodies and had axonal regeneration equivalent to nerve isografts, while treated STAT4 −/− mice demonstrated moderate axonal regeneration but inferior to the T helper cell Type 2–deficient animals. Enzyme-linked immunospot assay analysis demonstrated a minimal immune response in both STAT4 −/− and STAT6 −/− mice treated with a costimulatory blockade. Conclusions The authors' findings suggest that Type 1 T helper cells may play a more significant role in costimulatory blockade–induced immune hyporesponsiveness in the nerve allograft model, and that Type 2 T helper differentation may represent a potential target for directed immunosuppression.


1990 ◽  
Vol 87 (19) ◽  
pp. 7792-7796 ◽  
Author(s):  
M. P. Protti ◽  
A. A. Manfredi ◽  
C. Straub ◽  
J. F. Howard ◽  
B. M. Conti-Tronconi

1993 ◽  
Vol 92 (2) ◽  
pp. 1055-1067 ◽  
Author(s):  
A A Manfredi ◽  
M P Protti ◽  
M W Dalton ◽  
J F Howard ◽  
B M Conti-Tronconi

2008 ◽  
Vol 201-202 ◽  
pp. 41-49 ◽  
Author(s):  
Christine Jung ◽  
Christina Stoeckle ◽  
Karl-Heinz Wiesmüller ◽  
Rüdiger Laub ◽  
Frank Emmrich ◽  
...  

2018 ◽  
Vol 56 (01) ◽  
pp. E2-E89
Author(s):  
M Smits ◽  
C Fauvelle ◽  
T Baumert ◽  
C Neumann-Haefelin ◽  
R Thimme ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document